FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and medicine and concerns a therapeutic or preventive agent stimulating tissue cell migration of gastrointestinal mucosa, containing a peptide with the amino acid sequence Ser-Ser-Ser-Arg, or its pharmaceutically acceptable salt. Besides, the peptide with the amino acid sequence Ser-Ser-Ser-Arg or its pharmaceutically acceptable salt, and the peptide with the amino acid sequence Phe-Gly-Leu-Met-NH2 or its pharmaceutically acceptable salt are introduced in a combination. The declared agents are used in a method of treating pathology of gastrointestinal mucosa.
EFFECT: group of inventions provides synergetic action when is used in a combination, and can substantially induce wound healing in gastrointestinal mucosa.
14 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DOSING SCHEMES FOR ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE 2 (GLP-2) ANALOGUES | 2018 |
|
RU2785662C2 |
| ALPHA- AND GAMMA-MSH ANALOGUES | 2013 |
|
RU2668791C2 |
| USE OF NONPEPTIDE ANTAGONISTS OF TACHYKININ RECEPTORS | 1994 |
|
RU2146520C1 |
| PEPTIDE GLP-2 AGONISTS | 2010 |
|
RU2551977C2 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | 2014 |
|
RU2771808C2 |
| SPECIFIC ACTIVATOR AKT3 AND ITS USE | 2018 |
|
RU2815372C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| BIFIDOBACTERIUM BIFIDUM STRAINS FOR APPLICATION IN GASTROINTESTINAL DISEASES | 2012 |
|
RU2603285C2 |
